Compare FENG & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENG | VNRX |
|---|---|---|
| Founded | 1998 | N/A |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 22.5M |
| IPO Year | 2011 | 2012 |
| Metric | FENG | VNRX |
|---|---|---|
| Price | $1.77 | $0.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $2.00 |
| AVG Volume (30 Days) | 6.9K | ★ 6.9M |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $479.89 |
| Revenue Next Year | N/A | $538.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $1.43 | $0.15 |
| 52 Week High | $3.65 | $0.94 |
| Indicator | FENG | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 46.52 |
| Support Level | $1.74 | $0.17 |
| Resistance Level | $1.87 | $0.31 |
| Average True Range (ATR) | 0.03 | 0.01 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 25.00 | 51.17 |
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.